Randomized, Placebo-controlled, Double-blind, Cross-over Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)

NCT01928901 Phase 2 COMPLETED

Proof of concept: Superiority of Bronchipret or Sinupret to placebo in respect to mucociliary clearance

Details

Lead sponsor	Bionorica SE
Phase	Phase 2
Status	COMPLETED
Enrolment	56
Start date	2013-08
Completion	2014-02

Conditions

• Current Smokers

Interventions

• administration of Sinupret
• administration of Bronchipret
• administration of Sinupret Placebo
• administration of Bronchipret Placebo

Primary outcomes

• Time to perception of sweetness — after 7 days of treatment
  Time to perception of sweetness after 7 days of treatment with the investigational products - relative to the time to perception of sweetness at the begin-ning of treatment

Countries

Belgium